Related Experiment Video
Updated: May 11, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
[L-arginin in prevention and treatment of pre-eclampsia]
1Gynekologicko-Porodnické Oddĕrízská Nemocnice, a.s, Kromĕríz, Primár MUDr. J. Pribik. lukasvacula@email.cz
Objective:
It is to show the possible relationship between the patofysiology of pre-eclampsia in the body of a human with a relative lack of L-arginine and its potential connection with a nitrogen metabolism. This study also suggests the further utilization of above mentioned knowledges in a prevention and a treatment of pre-eclampsia.
Design:
Literary overview.
Setting:
Gynaecology and Obstetric Department of the Hospital Kromeriz, Inc., Kromeriz.
Methods:
The background research of studies and issues published already in medical professional journals, bulletins and medical web databases.
Conclusion:
To provide L-arginine to pregnant women as a dietary supplement concerns no risk and is an easy precaution. L-arginine can reduce the occurrance of pre-eclampsia in women with a potential high risk of its development. The most important transmitter substance that makes L-arginine work is the dioxide nitrogen. So far, it has been the outmost possibility how to influence the patofysiology of Pre-eclampsia The lack of L-arginine and its influence on the nitrogen metabolism is likely, but there is also a great need for further research.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Hormonal Regulation
Nephrotic Syndrome II : Assessment and Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...